MENU

CDC Recommends Moderna COVID-19 Vaccine for Children and Adolescents

On Thursday, June 23rd, CDC’s Advisory Committee on Immunization Practices (ACIP) expanded the recommendations for the use of Moderna COVID-19 vaccines to include children ages 6 through 17 years. They recommended Moderna’s COVID-19 vaccines in a 2-dose primary series for children ages 6 through 17 years and in a 3-dose primary series for children ages 6 through 17 years who are moderately or severely immunocompromised. CDC Director Dr. Rochelle Walensky endorsed that recommendation and released a statement

Moderna’s COVID-19 vaccines remain recommended for use for people 18 years of age and older as a primary series and as boosters and for children ages 6 months through 5 years as a primary series.

Moderna’s COVID-19 vaccines’ safety and effectiveness have been confirmed by clinical studies and by the millions of people who have already received them. As occurs for all vaccines—including all COVID-19 vaccines—safety monitoring will continue in all ages for whom Moderna vaccines are recommended and authorized. 

CDC recommends everyone ages 6 months and older get vaccinated against COVID-19. Everyone 5 years and older should also get a COVID-19 booster, if eligible. To learn if and when your child or teen can get boosters to stay up to date with their COVID-19 vaccines, use CDC’s COVID-19 booster tool.

Below is a list of resources and upcoming informational activities related to the recommendations:

Key Made to Save Resources

The following resources were compiled by Made to Save to assist in spreading accurate information about the vaccines, engaging in vaccine conversations, stemming the flow of mis- and disinformation, running equitable public health campaigns, and more. We hope that they are helpful in providing insight into our program and can be modified to assist with running future programs. You can find Made to Save’s full resource archive here.

The information on this page has been aggregated from the CDC and other trusted resources—is not medical advice, and was last updated 05/24/22. It may be out of date, so please check the factual accuracy of each post before sharing. If you have additional questions we encourage you to speak to a medical provider and visit COVID.gov

FDA Limits Use of Johnson & Johnson/Janssen COVID-19 Vaccine

Update Coming Soon on COVID-19 Vaccines for Children

  • CDC’s Advisory Committee on Immunizations Practices (ACIP) will meet on May 19th to discuss COVID-19 booster doses for children 5 to 11 years of age.
  • The U.S. Food & Drug Administration (FDA) has announced that its advisory committee will meet to discuss COVID-19 vaccines for children under 5 years of age on June 8, June 21, and June 22.
  • Recent research by the Kaiser Family Foundation (KFF) suggests low vaccine confidence among parents of children under the age of 5.
    • Of parents surveyed who had children younger than 5 years of age, about 18% said they intended to get their children vaccinated once COVID-19 vaccines are authorized this age group, while 38% said they would want to wait until they see the effects of the vaccine on other young children.
    • About 64% of the parents with children under the age of 5 who were surveyed said the postponement of meetings to discuss authorization of COVID-19 vaccines for children under the age of 5 has not affected their confidence in the safety of those vaccines.
    • KFF reports that while most parents feel their child is at least “somewhat safe” from COVID-19 at school, Black or Hispanic parents are less likely to feel their child is “very safe” than White parents, and are more likely to report mask use.

Moderna to Request FDA Authorization of a COVID-19 Vaccine for Children 6 months to Under 6 years

The request is based on interim data from the Phase 2/3 KidCOVE study of a 25 µg two-dose mRNA vaccine.

Moderna found that these doses “showed a robust neutralizing antibody response” similar to adults’ doses, with a “favorable safety profile.”

Click here to learn more.

CDC Recommends Additional Boosters for Certain Individuals

This decision follows the authorization by the U.S. Food & Drugs Administration (FDA) of the Pfizer-BioNTech COVID-19 vaccine or Moderna COVID-19 vaccine at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 Vaccine.

These updated recommendations apply to certain immunocompromised individuals and people over the age of 50 who received an initial booster dose at least 4 months ago.

Click here to learn more.

Additional COVID-19 at-home tests

Good News! Starting this week, if you already ordered 4 free at-home COVID-19 tests from COVIDtests.gov, now you can get 4 more free at-home tests shipped to your home.

Visit COVIDtests.gov again to place your second order. As before, just enter your name and mailing address (you can also give your email address if you want status updates on your order).

If you haven’t yet ordered any at-home tests, you can get a total of 8 tests shipped to your home. You’ll just have to place 2 separate orders – each order equals 4 tests.

At-home tests, or “self tests,” give rapid results and can be taken anywhere, regardless of your vaccination status or whether or not you have symptoms. Visit CDC.gov to learn when to test yourself, how to use an at-home test, and what your test results mean.

COVID-19 Testing Resources

A new resource, COVID-19 Testing Resources, is now live and can be found at the bottom of the COVID-19 Testing: What You Need to Know page.

Antigen Testing Guidance for SARS-CoV-2

Guidance for Antigen Testing for SARS-CoV-2 for Healthcare Providers Testing Individuals in the Community has been updated with information on when to consider confirmatory testing in symptomatic and asymptomatic individuals.

Monitoring COVID-19 Community Levels

A CDC Science Brief about Indicators for Monitoring COVID-19 Community Levels and Making Public Health Recommendations is now available. Check your county’s COVID-19 Community Level here. This data will be updated every Thursday.

Learn more about:

Skip to content